Xalkori 250 mg Alternative – Alkriz (Crizotinib) 250 mg Tablet | Beacon Pharmaceuticals

Alkriz 250 mg (Crizotinib) Tablet by Beacon Pharmaceuticals. Reference brand: Xalkori. ALK/ROS1 kinase inhibitor; used in molecularly selected non-small cell lung cancer. Prescription medicine. Brand comparison does not establish interchangeability.

Sutent 50 mg Alternative – Sunicent (Sunitinib) 50 mg Capsule | Incepta Pharmaceuticals

Sunicent 50 mg (Sunitinib) Capsule is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Sutent (Pfizer).

Pack: 12 capsules. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.

Jakafi / Jakavi 10 mg Alternative – Rulicent (Ruxolitinib) 10 mg Tablet | Incepta Pharmaceuticals

Rulicent 10 mg (Ruxolitinib) Tablet is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Jakafi / Jakavi (Incyte / Novartis).

Pack: 10 tablets. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.

Jakafi / Jakavi 5 mg Alternative – Rulicent (Ruxolitinib) 5 mg Tablet | Incepta Pharmaceuticals

Rulicent 5 mg (Ruxolitinib) Tablet is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Jakafi / Jakavi (Incyte / Novartis).

Pack: 14 tablets. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.

Stivarga 40 mg Alternative – Regocent (Regorafenib) 40 mg Tablet | Incepta Pharmaceuticals

Regocent 40 mg (Regorafenib) Tablet is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Stivarga (Bayer).

Pack: 10 tablets. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.

Ibrance 125 mg Alternative – Palbocent (Palbociclib) 125 mg Capsule | Incepta Pharmaceuticals

Palbocent 125 mg (Palbociclib) Capsule is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Ibrance (Pfizer).

Pack: 21 capsules. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.

Tagrisso 80 mg Alternative – Osicent (Osimertinib) 80 mg Tablet | Incepta Pharmaceuticals

Osicent 80 mg (Osimertinib) Tablet is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Tagrisso (AstraZeneca).

Pack: 10 tablets. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.

Ofev 150 mg Alternative – Ninacent (Nintedanib) 150 mg Capsule | Incepta Pharmaceuticals

Ninacent 150 mg (Nintedanib) Capsule is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Ofev (Boehringer Ingelheim).

Pack: 10 capsules. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.

Ofev 100 mg Alternative – Ninacent (Nintedanib) 100 mg Capsule | Incepta Pharmaceuticals

Ninacent 100 mg (Nintedanib) Capsule is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Ofev (Boehringer Ingelheim).

Pack: 10 capsules. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.

Vitrakvi 100 mg Alternative – Larocent (Larotrectinib) 100 mg Capsule | Incepta Pharmaceuticals

Larocent 100 mg (Larotrectinib) Capsule is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Vitrakvi (Bayer).

Pack: 12 capsules. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.

Tykerb / Tyverb 250 mg Alternative – Lapacent (Lapatinib) 250 mg Tablet | Incepta Pharmaceuticals

Lapacent 250 mg (Lapatinib) Tablet is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Tykerb / Tyverb (Novartis).

Pack: 12 tablets. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.

Imbruvica 140 mg Alternative – Ibrucent (Ibrutinib) 140 mg Capsule | Incepta Pharmaceuticals

Ibrucent 140 mg (Ibrutinib) Capsule is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Imbruvica (Pharmacyclics / Janssen).

Pack: 12 capsules. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.